Glioma Recurrence after Surgery or Radiation Therapy
- Gliomas are difficult to treat fully because they don’t have clear boundaries and are infiltrative (spreading into nearby brain tissue), which makes complete removal challenging.
- Surgery aims to remove as much of the tumor as safely as possible, but even skilled surgeons may leave behind some cancer cells to avoid damaging healthy brain tissue.
- Cancer stem cells in gliomas may be able to survive treatments, making them especially resistant and likely to cause recurrence over time.
- Radiation and chemotherapy help target remaining cancer cells but may not eliminate all of them, especially if some cells are resistant to these therapies.
- Molecular testing and ongoing research are exploring ways to target specific cells responsible for tumor regrowth, providing hope for more effective treatments in the future.
The Challenge of Treating Gliomas
Gliomas are tumors that grow from glial cells, which are supportive cells in the brain that surround and protect nerve cells. Unlike many other tumors, gliomas don’t have defined edges. This certain characteristic is known as “infiltrative,” meaning they spread into nearby brain tissue rather than staying in one defined area. Because of this, it’s challenging for surgeons to remove every single cancer cell, even with the best surgical techniques.
Why Surgery Alone Can’t Always Cure Gliomas
Read MoreThe Role of ‘Cancer Stem Cells’ in Recurrence
One theory that researchers are studying involves something called cancer stem cells. These cells are thought to be especially resistant to treatments like surgery and radiation. Dr. Thompson explains that while most of the tumor cells may be destroyed by treatment, a small number of these cancer stem cells can survive and later “fuel” the tumor’s regrowth.
“These tumors don’t have a hard edge. They’re super toxic to the brain, gathering a blood supply and creating swelling and inflammation,” Dr. Thompson says. He adds that these cancer stem cells are tough to target because they often remain dormant during treatment, only to become active later.
Radiation & Chemotherapy Aren’t Always Enough
After surgery, many patients receive radiation therapy to target leftover tumor cells. Radiation works by using high-energy X-rays to damage the DNA of cancer cells, which can stop them from growing. Chemotherapy, which uses drugs to kill cancer cells, is another common treatment for gliomas.
While these treatments can help reduce the tumor’s size and slow its growth, they can’t always eliminate every cancer cell, as some cells may be resistant to radiation and/or chemotherapy.
This resistance is one of the reasons why gliomas are so challenging to treat. Standard treatments can shrink the tumor, but they may not completely get rid of the cancer.
Ongoing Research & Hope for the Future
Research is continuously evolving, and scientists are learning more about how to target these difficult cancer stem cells. Dr. Thompson mentions that one promising area of research involves understanding the unique “fingerprint” of each patient’s tumor at a molecular level. By studying these fingerprints, or molecular profiles, doctors hope to find new treatments that specifically target the cells most likely to cause recurrence.
In his interview with SurvivorNet, Dr. Thompson expressed optimism for the future: “There’s a lot of cool insight happening on the research front, and it gives those of us who take care of patients with gliomas and glioblastomas a lot of hope because it gives us hope for the future.”
In summary, gliomas are challenging to treat because they spread into nearby healthy brain tissue and often contain cancer stem cells. These characteristics make it difficult to completely resect them and resistant to standard treatments. Surgery, radiation, and chemotherapy each play a role in managing the tumor, but even with these approaches, gliomas can return. Researchers like Dr. Thompson are continually searching for better ways to target these stubborn cells and prevent recurrence, bringing hope for new, more effective treatments in the future.
Dr. Thompson emphasized to SurvivorNet that each glioma is unique, and understanding these differences is key to advancing treatment options. “No two gliomas are exactly the same,” he says, highlighting the importance of individually tailored treatment approaches.
With the right information, patients and families can feel more empowered and better prepared for the challenges that may lie ahead in the journey of glioma treatment.
Questions to Ask Your Doctor
If you or a loved one has been treated for a glioma, it’s important to understand the risk of recurrence and discuss ongoing care with your doctor. Here are some questions to ask:
- What are the chances that my glioma will return after treatment?
- Are there any specific cancer cells that might be resistant to treatment in my case?
- What follow-up treatments are available to help reduce the risk of recurrence?
- How often should I have check-ups or scans after my treatment?
- Are there any clinical trials or new therapies that might be effective if my glioma returns?
Patients should stay informed and discuss any concerns with their care team, emphasizing that understanding the nature of gliomas can help patients and families make well-informed decisions.
Learn more about SurvivorNet's rigorous medical review process.